Skip to main content

Biomy, Inc.

The startup provides an AI-driven spatial analysis platform that utilizes machine learning algorithms to identify and characterize cancerous tumors. This technology enhances the pharmaceutical sector's ability to develop targeted therapies by delivering precise biological insights into complex diseases.

Traction 3/10
Tokyo, Japan · HQ
Founded 20197300+ followers
  • Artificial Intelligence
  • Data & Analytics
  • Biotechnology
Updated 6 months ago

Funding

Raised to date

$580KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

2 founders

Teppei Konishi

CEO

Joel BERNIAC

President & Founder

Product

Features

  • The startup provides an AI-driven spatial analysis platform that utilizes machine learning algorithms to identify and characterize cancerous tumors. This technology enhances the pharmaceutical sector's ability to develop targeted therapies by delivering precise biological insights into complex diseases.
This profile is AI-generated and may contain inaccuracies.